TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03275337

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: tDCS is a non-invasive form of neuromodulation in which direct current is administered placed over a brain region of interest to induce physiological changes such as inhibition or excitation over that region.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation
Description: tDCS is a non-invasive form of neuromodulation in which direct current is administered placed over a brain region of interest to induce physiological changes such as inhibition or excitation over that region.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: tDCS is a non-invasive form of neuromodulation in which direct current is administered placed over a brain region of interest to induce physiological changes such as inhibition or excitation over that region.
Study: NCT02620007

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin
Description: oral Rifaximin 800 mg bid for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ciprofloxacin Placebo
Description: a placebo of Ciprofloxacin bid for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Rifaximin Placebo
Description: a placebo of Rifaximin bid for 12 weeks
Study: NCT04300439

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: knee total arthroplasty with two types of ancillaries
Description: -For the Arm A, the surgical procedure of knee total arthroplasty will be done with metallic reusable ancillary.~For the Arm B, the surgical procedure of knee total arthroplasty will be done with Efficiency single use ancillary.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: knee total arthroplasty with two types of ancillaries
Description: -For the Arm A, the surgical procedure of knee total arthroplasty will be done with metallic reusable ancillary.~For the Arm B, the surgical procedure of knee total arthroplasty will be done with Efficiency single use ancillary.
Study: NCT02770833

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fish and carbohydrats with low or high GI

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fish and carbohydrats with low or high GI

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Veal and carbohydrats with low or high GI

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Veal and carbohydrats with low or high GI
Study: NCT01649388

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: FCR001
Description: Enriched hematopoietic stem cell infusion
Study: NCT01262573

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Closure of vaginal cuff
Description: Closure of the vaginal cuff

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Closure of vaginal cuff
Description: Closure of the vaginal cuff
Study: NCT02380001

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol
Description: White round pill containing 25mg of Dexketoprofen will be administered either prior/after to third molar surgery.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Preoperative control
Description: white round pill containing 25mg of placebo will be administered prior/after to third molar surgery. The placebo pill is identical to active dexketoprofen, in size and color
Study: NCT02315573

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wrist block anesthesia
Description: The carpal tunnel release surgery will be performed under wrist block anesthesia. Group 1 will have the wrist block performed with Lidocaine and epinephrine, while Group 2 with Bupivacaine and epinephrine.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wrist block anesthesia
Description: The carpal tunnel release surgery will be performed under wrist block anesthesia. Group 1 will have the wrist block performed with Lidocaine and epinephrine, while Group 2 with Bupivacaine and epinephrine.
Study: NCT02350569

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LDV/SOF
Description: 90/400 mg FDC tablet administered orally
Study: NCT00857428

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxymorphone
Description: Tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxymorphone
Description: 40 mg tablets
Study: NCT03800173

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: galidesivir
Description: galidesivir IV infusion

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo IV infusion
Study: NCT04193358

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: FERTILIS HOMME®
Description: L-carnitine 220 mg, Zinc 20 mg, Selenium 0.03 mg, L-arginine 125 mg, L-glutathione 40 mg, Folic acid (vitamin B-9) 0.4 mg, Coenzyme Q10 7.5 mg, and Vitamin E 60 mg

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: Sugar pills
Study: NCT03178331

Intervention type: OTHER
Intervention: Study questionnaires
Description: filled by parents, school nurse and teacher

Intervention type: OTHER
Intervention: Study questionnaires
Description: filled by parents, school nurse and teacher
Study: NCT02368704

Intervention type: OTHER
Intervention: No intervention

Intervention type: OTHER
Intervention: No intervention
Study: NCT04151173

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: laparoscopic aspiration/electrocoagulation
Description: laparoscopic aspiration/electrocoagulation of ovarian endometrioma

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic cystectomy
Description: laparoscopic cystectomy of ovarian endometrioma
Study: NCT00331422

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: Carboplatin dose (milligrams (mg)) - Target Area Under the Curve (AUC) 6 x (Glomerular Filtration Rate+25) - Calvert Formula, given intravenously (IV) for 30 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: Paclitaxel dose = 175 milligrams per meter squared (mg/m2) over 3 hours.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cytoreductive surgery
Description: Surgery - tumor specimen collected for extreme drug resistant assay (EDR) and A1 assays for analysis
Study: NCT02805972

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxone
Description: 4 mg / 0.1 ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naloxone
Description: 4 mg / 0.1 ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.1 ml

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 0.1 ml
Study: NCT00496509

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD6474 (Zactima) 100mg

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MR)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MR)

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biomarker Draws

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biomarker Draws

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZD6474 (Zactima) 300mg
Study: NCT00412997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBH589
Study: NCT01384942

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Meaning-Based Bereavement Group
Description: A 12 week bereavement counselling group with tasks and themes that focus on re-constructing meaning following death.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Bereavement Group
Description: An 8 week traditional bereavement group that follows a more conventional approach to grief support.
Study: NCT04126018

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI with strain measurement
Description: CMR measurements of left and right ventricular systolic function strain and myocardial fibrosis

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI with strain measurement
Description: CMR measurements of left and right ventricular systolic function strain and myocardial fibrosis

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI with strain measurement
Description: CMR measurements of left and right ventricular systolic function strain and myocardial fibrosis

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI with strain measurement
Description: CMR measurements of left and right ventricular systolic function strain and myocardial fibrosis

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Doppler, PISA, VCA, volumetric method as performed during echocardiography

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Doppler, PISA, VCA, volumetric method as performed during echocardiography

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Doppler, PISA, VCA, volumetric method as performed during echocardiography

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiography
Description: Doppler, PISA, VCA, volumetric method as performed during echocardiography
Study: NCT06702839

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BETY (Cognitive Exercise Therapy Approach )
Description: Individuals with rheumatism were included in BETY sessions after the first session, which included functional gain with function-focused trunk stabilization exercises for their complaints and chronic pain management training based on neuroscience. BETY sessions included function-focused trunk stabilization exercises, chronic pain management, mood information management (dance therapy - authentic movement) as innovative. Individuals were included in a separate session of sexual information management and sleep education.~3 days a week for 3 months

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home exercise program
Description: Exercises have been shown and a brochure has been given The individuals in this group were mostly individuals from out of town who were given home exercise recommendations directed by a rheumatologist.
Study: NCT00189007

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allopurinol sodium
Description: Allopurinol sodium 500 mg / 50 mL, intravenously, single dose

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Mannitol
Description: Mannitol 500 mg/50 mL water for injection, intravenously, single dose
Study: NCT00252486

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Flax oil
Description: Flax oil and olive oil placebo were analyzed for quality and purity; sufficient bioactivity was confirmed for the flax oil independently at the University of Massachusetts mid-way through the study. Each capsule of omega -3 fatty acid concentrate contained 550 mg of α-linolenic acid (α-LNA) from flax seed oil.A stepped but flexible dose-titration schedule was carried out with doses increased by 1-2 grams at each visit as tolerated, to an attempted total dose of 6 capsules twice per day, as requested by the FDA (up to 6.6 grams of daily α-linolenic acid).
Study: NCT03405896

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Turning
Description: start to walk with normal speed, and then turn to approach the terminal under different angle.
Study: NCT03239600

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK2618960 2 mg/kg
Description: GSK2618960 solution for injection, 100mg/mL is clear to opalescent, colorless to yellow or pale brown liquid.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo solution will be administered by IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: MTX dose between 7.5 to 15 mg will be administered in tablet form once in a week till last dose of GSK2618960 to all subjects in Part I and Part II.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Methotrexate
Description: MTX dose between 7.5 to 15 mg will be administered in tablet form once in a week till last dose of GSK2618960 to all subjects in Part I and Part II.
Study: NCT01927627

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: enzalutamide
Description: oral therapy with enzalutamide at 160mg (4 capsules) orally once daily (QD).
Study: NCT03090438

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Varicocele embolization
Description: Ultrasound guided right internal jugular vein access with placement of a vascular sheath. Fluoroscopically guided selective catheterization of the left and right (if bilateral) spermatic veins to the level of the inguinal ligament. Occlusion of the spermatic vein(s) by embolization coils and a sclerosing agent (sodium tetradecyl sulphate 3%).
Study: NCT02212470

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Drug Eluting Balloon Angioplasty
Description: Angioplasty with Drug eluting balloon after pre dilatation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nitinol stenting
Description: Nitinol stent deployment
Study: NCT04197531

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Irrigation Method
Description: Irrigation Method

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Irrigation Method
Description: Irrigation Method
Study: NCT00384254

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5 A
Description: Dental providers are trained to provide Ask, Advise, Assess, Assist and Arrange to all tobacco using patients. Written materials are provided, including information on local cessation resources, pharmacotherapy and tobacco quitlines.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 3 A
Description: Providers are trained to provide Ask, Advise and Arrange intervention to all tobacco using patients. Written materials, prescription for NRT and a Fax-to-Quit referral are provided.
Study: NCT04203810

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)
Description: 4 puffs to be administered as needed several times a day for patients aged ≥ 12 years. A maximum of 10 applications per day should not be exceeded.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EMSER® Hals-und Rachenspray (throat spray)
Description: 1 to 3 puffs to be administered several times a day
Study: NCT00586651

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lestaurtinib
Description: 60 mg bid - 120 mg bid for an 18 weeks (126 days) treatment duration
Study: NCT03576495

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PACTS curriculum
Description: The cultural dexterity curriculum, known as PACTS (Provider Awareness Cultural Dexterity Toolkit for Surgeons) focuses on developing cognitive skills to adapt to individual patients' needs to ensure personal, patient-centered surgical care.~The curriculum is comprised of four educational modules on establishing trust in the physician-patient relationship, communicating effectively with patients with limited English proficiency, discussing informed consent, and issues surrounding pain management. Each module consists of an independent learning activity, an interactive role-play, and a post-lesson assessment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Residency Curriculum
Description: The standard residency curriculum consists of previously scheduled resident didactic sessions at all academic medical centers that may or may not include topics on cultural competency or cross-cultural care.
Study: NCT04016883

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Problem Solving Therapy offered through a web platform
Description: Problem Solving Therapy offered through a web platform. There will be four sessions, during the first four weeks of treatment, and subsequent sessions are dedicated to refining problem-solving skills. Participants set treatment goals; different ways to reach goals are discussed and evaluated; action plans are created, and its effectiveness is evaluated to achieve the objectives. Participants are expected to implement plans and apply the problem-solving model to additional problems between sessions. In the last two sessions, participants create a relapse prevention plan using the problem-solving therapy model.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Conventional web platform
Description: The conventional web platform, which will contain the general content on stress coping techniques.
Study: NCT04229446

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music based caregiving
Description: The intervention (MBC) consists of daily individualized prerecorded music integrated with activity with about 30 minutes duration, combined with a one hour active session in groups twice weekly. The music will be selected based on individualized preferences from the patients or their family. The music will also be adapted to the day rhythm; awakening in the morning, support activities during the day, or for sleep in the evening. The healthcare worker will bring playback equipment e.g. a CD-player to the patient room. In addition will two weekly sessions in groups be performed (each on one hour) with music and movement.
Study: NCT03801304

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab in IV infusions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinorelbine
Description: Vinorelbine capsules
Study: NCT03684161

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary function
Description: Body composition measurements; Pulmonary function tests; Cardiopulmonary exercise test; Force frequency releationship, ultrasound

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary function
Description: Body composition measurements; Pulmonary function tests; Cardiopulmonary exercise test; Force frequency releationship, ultrasound

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiopulmonary function
Description: Body composition measurements; Pulmonary function tests; Cardiopulmonary exercise test; Force frequency releationship, ultrasound
Study: NCT04473443

Intervention type: OTHER
Intervention: FEops HEARTguideTM
Description: A patient-specific computer simulation that aims to improve the outcomes after TAVI by suggesting THV platform, THV size and implantation depth with the use of the pre-procedural CT-scan.

Intervention type: OTHER
Intervention: FEops HEARTguideTM
Description: A patient-specific computer simulation that aims to improve the outcomes after TAVI by suggesting THV platform, THV size and implantation depth with the use of the pre-procedural CT-scan.
Study: NCT05057585

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Turning in bed, arm and leg exercises
Description: Exercises (arm and leg exercises, turning in bed) were applied only to the experimental group. It was applied for 15 minutes 12-24 hours before the operation.
Study: NCT01617681

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAL489
Description: Valsartan 3mg/kg oral solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAL489
Description: Valsartan 3mg/kg oral solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAL489
Description: Valsartan 3mg/kg oral solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAL489 matching placebo
Description: Valsartan 3 mg/kg oral solution

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAL489 matching placebo
Description: Valsartan 3 mg/kg oral solution
Study: NCT04838691

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: interpersonal counseling
Description: In the intervention group, it will be administered for 40 minutes for 8 weeks to people with symptoms of premenstrual syndrome.
Study: NCT04475185

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MakAir
Description: MakAir artificial ventilator
Study: NCT03081910

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Autologous CD5.CAR/28zeta CAR T cells
Description: Three dose levels will be evaluated:~Dose level one: 1×10\^7 cells/m2~Dose level two: 5×10\^7 cells/m2~Dose level three: 1×10\^8 cells/m2

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Allogeneic CD5.CAR/28zeta CAR T cells
Description: Three dose levels will be evaluated:~Dose level one: 1×10\^7 cells/m2~Dose level two: 5×10\^7 cells/m2~Dose level three: 1×10\^8 cells/m2
Study: NCT03120559

Intervention type: DEVICE
Group type: OTHER
Intervention: New Floss Holder - Gum Chucks
Description: Dental inter-proximal control with GumChucks floss holder

Intervention type: DEVICE
Group type: OTHER
Intervention: New Floss Holder - Gum Chucks/SMS
Description: Dental inter-proximal control with GumChucks floss holder and receiving 16 SMS during first 4 months.
Study: NCT02831244

Intervention type: DEVICE
Group type: OTHER
Intervention: Agili-CTM
Description: Consenting individuals will be selected from the population of patients with osteoarthritis of the great toe examined by a participating investigator. Following signing an informed consent, candidates will be evaluated by an adjudication committee for possible inclusion in the trial based on medical history and Standing Foot X-ray. Candidates that are approved or conditionally approved by the adjudication committee will undergo Agili-CTM implantation procedure
Study: NCT02108782

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dovitinib lactate
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT05576675

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sufentanil + nalbuphine
Description: sufentanil 100 μ g + nalbuphine 40 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sufentanil
Description: sufentanil 200 μ g

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hydromorphone + nalbuphine
Description: hydromorphone 10 mg+ nalbuphine 40 mg
Study: NCT03814473

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diet
Description: Participants provided with a brochure providing a thorough description of the diet, \~8 example recipes for each meal (i.e. breakfast, lunch, dinner, and snacks) included as a sample menu, and guidance to assist in shopping and self-preparation of food for the prescribed diet and to improve adherence. Diet consisted of following the popular paleolithic diet